Patent 11603542 was granted and assigned to Voyager Therapeutics on March, 2023 by the United States Patent and Trademark Office.
The present invention relates to adeno-associated viral (AAV) particles encoding siRNA molecules and methods for treating amyotrophic lateral sclerosis (ALS).